CLINICAL TRIALS PROFILE FOR CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
✉ Email this page to a colleague
All Clinical Trials for CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00741897 ↗ | Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis | Completed | Sanofi | Phase 4 | 2002-03-01 | To determine the safety and efficacy of Fexofenadine (Telfast®) 30mg pediatric tablets on Filipino children aged 6 to 11 for the relief of symptoms associated with perennial and intermittent allergic rhinitis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
Condition Name
Clinical Trial Locations for CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
Clinical Trial Progress for CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
Clinical Trial Phase
Clinical Trial Sponsors for CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
Sponsor Name